News Archives

4 05, 2022

FDA fast tracks unique next-generation gene-edited therapy for sickle cell disease patients
Gallery

FDA fast tracks unique next-generation gene-edited therapy for sickle cell disease patients

webmaster2024-07-10T19:30:59+00:00

Graphite Bio is a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious diseases. The FDA has just granted Fast Track Designation to GPH101 for the treatment of sickle cell disease (SCD). GPH101 is an investigational next-generation gene-edited autologous [...]

FDA fast tracks unique next-generation gene-edited therapy for sickle cell disease patientswebmaster2024-07-10T19:30:59+00:00

16 02, 2021

Avance Biosciences™ Expanding Houston Campus
Gallery

Avance Biosciences™ Expanding Houston Campus

webmaster2024-07-10T19:33:13+00:00

HOUSTON, Feb. 16, 2021 /PRNewswire/ -- Avance Biosciences™, a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services supporting biological drug development and manufacturing, announced today that its Houston facility, which successfully passed an inspection by the U.S. Food and Drug Administration in Oct 2018, is undergoing major expansion to handle rapidly growing demand for their services. [...]

Avance Biosciences™ Expanding Houston Campuswebmaster2024-07-10T19:33:13+00:00

7 12, 2020

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company
Gallery

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company

webmaster2022-05-05T13:21:09+00:00

Pharm Tech Outlook, a highly respected pharmaceutical/biotech industry magazine, has recognized Avance Biosciences™ as a top 10 Genomics Solutions Company for 2020. Genomic technologies and their usage have seen extensive growth in the past decade. Over the years, these technologies have evolved significantly and can now be used [...]

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Companywebmaster2022-05-05T13:21:09+00:00

30 10, 2018

Avance Biosciences™ Completes Successful FDA Inspection
Gallery

Avance Biosciences™ Completes Successful FDA Inspection

webmaster2023-04-11T14:25:35+00:00

HOUSTON, Oct. 30, 2018 - Avance Biosciences™, Inc., a leading biological testing company supporting drug development and manufacturing, announced today that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018. This inspection focused on the firm’s quality management system, operation procedures, and data integrity, as [...]

Avance Biosciences™ Completes Successful FDA Inspectionwebmaster2023-04-11T14:25:35+00:00

25 03, 2012

Avance Biosciences™ Signed MSA

webmaster2024-11-12T13:49:51+00:00

In the week of March 18, 2012, Avance Biosciences™ entered a Master Service Agreement (MSA) with a global leader in custom biologics manufacturing. Based on this agreement, Avance Biosciences™ will provide its GMP level Cell Bank Characterization services, including DNA Sequencing, qPCR, Southern blot and other molecular biological methods, to characterize the Master Cell Bank (MCB), Working Cell Bank (WCB), and End of Production Cells (EOPC) submitted by the clients.

Avance Biosciences™ Signed MSAwebmaster2024-11-12T13:49:51+00:00

5 07, 2011

New Website – Avance Biosciences™ Inc.

webmaster2024-11-12T13:50:03+00:00

To Our Esteemed Customers and Friends: We would like to bring to your attention that Avance Biosciences™ Inc. has been formed by a group of experienced genomic scientists, quality professionals, biotechnology services experts, and enthusiastic investors. The founders of the company, combined, have more than 100 years of experience in the genomics and biotechnology [...]

New Website – Avance Biosciences™ Inc.webmaster2024-11-12T13:50:03+00:00